Determining Elemental Impurities in Pharmaceutical Ingredients using ICP-MS

Application Note Pharmaceuticals Validating performance of an Agilent ICP‑MS for USP <232>/<233> & ICH Q3D(R2)/Q2(R1) Reducing the time and expense of ICP-MS method development and system validation for measuring elemental impurities in pharmaceuticals Authors Lindsey Whitecotton, Ed McCurdy, Craig Jones…

Application Note Pharma & Biopharma Analysis of Artificial Tear Eye Drops For Elemental Impurities Using an ICP-MS and USP <232>/<233> and ICH Q3D(R2)/Q2(R1) protocols. Authors Jennifer Sanderson and Lindsey Whitecotton Agilent Technologies, Inc. Introduction As pharmaceutical products are released to…

APPLICATION NOTE 44385 Analysis of elemental impurities in drug products using the Thermo Scientific iCAP 7400 ICP-OES Duo Authors Introduction Sanja Asendorf, Application Specialist, Thermo Fisher Scientific, Bremen, Germany Impurities in pharmaceutical products are of great concern not only due…

Application News No. AD-0189 Elemental Analysis: ICPMS-2030 Validation of quantitative method for determination of elemental impurities in pharmaceutical products following USP 232/233 on ICPMS-2030 Raymond Li , Zhaoqi Zhan Overview The 24 elemental impurities defined in USP<232> in three generic…